$4350 | Site License
$9500 | Global License

Carcinoembryonic Antigen (CEA): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
[Lowest Price Guaranteed: $4,350]

Published by Venture Planning Group (VPG): 24 Jun 2016 | 58802 | In Stock

Introduction

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 250 pages and 15 tables

Table of Contents
for Carcinoembryonic Antigen (CEA): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • Table of Content - click REQUEST A SAMPLE BUTTON

List Of Tables
in Carcinoembryonic Antigen (CEA): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Company Assessments

- Abbott

- AdnaGen/Alere

- Agilent Technologies

- Applied Gene Technologies

- Arca Biopharma

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomedical Diagnostics

- bioMerieux

- Bio-Rad

- CellSearch

- Cepheid

- Correlogic Systems/Vermillion

- Decode Genetics

- Diadexus

- Diagnocure

- Diasorin

- Eiken Chemical

- Elitech Group

- Enterix

- Enzo Biochem

- Epigenomics

- Fujirebio

- Guided Therapeutics

- Hologic/Gen-Probe

- Kreatech/Leica

- Kyowa Medex

- Mackay Life Sciences

- Myriad Genetics

- OncoLab

- Ortho-Clinical Diagnostics

- Panacea Pharmaceuticals

- Polartechnics

- Polymedco

- PreMD

- Qiagen

- Quest Diagnostics

- Radient Pharmaceuticals

- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Thermo Fisher

- Tosoh

- Veridex

- Wako Pure Chemicals

- Wallac/PE

- Zila

Additional Details

Publisher

Venture Planning Group (VPG)

Publisher Information

Reference

58802 | VPCA18877

Number of Pages

250

Report Format

PDF

Venture Planning Group (VPG) Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2018
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconi...
14 Aug 2018 by Global Markets Direct USD $3,500 More Info
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2018
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconi...
20 Feb 2018 by Global Markets Direct USD $3,500 More Info
Global and Chinese Carcinoembryonic Antigen Industry, 2017 Market Research Report
The 'Global and Chinese Carcinoembryonic Antigen Industry, 2012-2022 Market Research Report' is a pr...
29 Dec 2017 by Prof Research USD $3,000 More Info
Carcinoembryonic Antigen (CEA) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
The cancer diagnostics market is on the verge of explosion, as the researchers approach major techno...
09 Dec 2017 by Venture Planning Group (VPG) USD $4,350 More Info
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2017
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconi...
29 Aug 2017 by Global Markets Direct USD $3,500 More Info
Carcinoembryonic Antigen (CEA) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
The cancer diagnostics market is on the verge of explosion, as the researchers approach major techno...
30 Mar 2017 by Venture Planning Group (VPG) USD $4,350 More Info
Carcinoembryonic Antigen (CEA) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
The cancer diagnostics market is on the verge of explosion, as the researchers approach major techno...
09 Dec 2016 by Venture Planning Group (VPG) USD $2,800 More Info
Carcinoembryonic Antigen (CEA) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
The cancer diagnostics market is on the verge of explosion, as the researchers approach major techno...
09 Dec 2016 by Venture Planning Group (VPG) USD $4,350 More Info
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2016
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconi...
09 Nov 2016 by Global Markets Direct USD $3,500 More Info
Carcinoembryonic Antigen (CEA): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
The cancer diagnostics market is on the verge of explosion, as the researchers approach major techno...
24 Jun 2016 by Venture Planning Group (VPG) USD $4,350 More Info

This report is published by Venture Planning Group (VPG)

Download Free Report Summary PDF

Carcinoembryonic Antigen (CEA): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...